Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
172 people get CHE articles and Market Currents by email alert.
Get email alerts on CHE »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Chemed Urges Stockholders to Ignore Millbrook CapitalTodd Walker • Mon, May 18, 2009 -
-
Chemed Corporation Showing Strong GrowthZacks Investment Research • Fri, Nov 28, 2008 -
-
Chemed Corp.: Major Player in Hospice and PlumbingZacks Investment Research • Mon, Feb 26, 2007
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
15 Small-Cap Rockets In An Unexpected SectorKurtis Hemmerling • Sun, Dec 11, 2011 -
-
-
4 Healthcare Dividend Stocks With Impressive ProfitabilityKapitall • Mon, Sep 19, 2011
-
5 Healthcare Dividend Stocks Being Bought By Smart MoneyKapitall • Wed, Sep 7, 2011
-
-
-
-
-
-
-
Chemed Corporation Q4 2008 Earnings Call TranscriptTue, Feb 17, 2009
-
Chemed Corporation, Q3 2008 Earnings Call TranscriptWed, Oct 22, 2008
-
Chemed Corporation Q2 2008 Earnings Call TranscriptTue, Jul 29, 2008
-
CHEMED Corporation Q1 2008 Earnings Call TranscriptMon, May 19, 2008
-
Chemed Corporation Q4 2007 Earnings Call TranscriptFri, Feb 22, 2008
-
Business Wire (May 30, 2013)
-
Business Wire (May 23, 2013)
-
Business Wire (May 20, 2013)
-
Business Wire (May 14, 2013)
-
Business Wire (May 6, 2013)
-
at MarketWatch.com (May 3, 2013)
-
Business Wire (May 3, 2013)
-
Business Wire (Apr 18, 2013)
-
Business Wire (Apr 5, 2013)
-
Business Wire (Mar 6, 2013)
-
Business Wire (Feb 21, 2013)
-
Business Wire (Feb 18, 2013)
-
Business Wire (Jan 31, 2013)
-
Business Wire (Jan 22, 2013)
-
Business Wire (Jan 2, 2013)
-
Business Wire (Dec 6, 2012)
-
Business Wire (Nov 9, 2012)
-
Business Wire (Nov 7, 2012)
-
Business Wire (Oct 29, 2012)
CHE vs. ETF Alternatives
Company Description
Currently, there's no company description for CHE.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Monday, May 20, 4:58 PM Chemed (CHE) declares $0.18/share quarterly dividend, in line with previous. Forward yield 1.05%. For shareholders of record May 30. Payable June 19. Ex-div date May 28. (PR) Comment! [Dividends]
- Friday, May 10, 2:00 PM Chemed (CHE -5.3%) takes a hit from a negative Citron Research report calling it 'Game Over' for the shares. Citron says that the recent False Claims suit filed against the company's VITAS business units is just the tip of the spear. Not only has the analyst community overlooked a second, equally damaging suit that was filed, but the government's takeover of the investigation means a potential trebling of damages against the company. Comment! [Healthcare, On the Move]
- Friday, May 3, 9:27 AM Chemed (CHE) -16.2% premarket after the U.S. sues the hospice chain and several of its subsidiaries, alleging they submitted false Medicare billings for services that misspent "tens of millions of taxpayer dollars." In one instance cited by the government, CHE subsidiary Vitas Hospice billed a patient for care he didn't need and at a time when he was actually playing bingo. Comment! [Healthcare, On the Move]
-
Friday, May 3, 9:10 AM
Premarket gainers: PKT +32%. YRCW +27%. INVN +18%. YY +8%. DDD +5%.
Losers: VCRA -35%. ZAGG -24%. GUID -23%. CHE -16%. ARNA -13%. CETV -13%. HMY -9%. LNKD -9%. AGNC -6%. RBS -6%. 3 Comments [On the Move] - Thursday, April 18, 4:33 PM Chemed (CHE): Q1 EPS of $1.38 beats by $0.08. Revenue of $367M (+3.9% Y/Y) beats by $1.92M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Wednesday, February 20, 3:50 PM Chemed Corporation (CHE) declares $0.18/share quarterly dividend, in line with previous. Forward yield 0.92%. For shareholders of record Mar. 04. Payable Mar. 22. Ex-div date Feb. 28. (PR) Comment! [Dividends]
- Sunday, November 11, 2012, 3:52 AM Chemed Corp (CHE) declares $0.18/share quarterly dividend, in line with previous. Forward yield 1.11%. For shareholders of record Nov. 19. Payable Dec. 10. Ex-div Nov. 15. (PR) Comment! [Dividends]
- Friday, November 2, 2012, 10:38 AM Chemed (CHE -3%) discloses in a regulatory filing that in July it received an investigative subpoena from the Florida Attorney General seeking a variety of documents - of which it had previously produced in the course of prior government investigations - regarding billing records and procedures, patient eligibility for hospice care, plus other matters pertaining to its general business operations. 2 Comments [Healthcare, On the Move]
- Monday, October 29, 2012, 2:12 PM Chemed (CHE): Q3 EPS of $1.28 misses by $0.07. Revenue of $354M (+3.8% Y/Y) misses by $6M. (PR) Comment! [Earnings, Healthcare]
- Friday, August 3, 2012, 2:27 PM Chemed (CHE) declares $0.18/share quarterly dividend, 12.5% increase from prior dividend of $0.16. Forward yield 1.05%. For shareholders of record Aug 13. Payable Sep 04. Ex-div date Aug 09. (PR) Comment! [Dividends]
- Wednesday, July 25, 2012, 4:59 PM Chemed (CHE): Q2 EPS of $1.26 in-line. Revenue of $354.2M (+6.2% Y/Y) beats by $0.59M. (PR) Comment! [Earnings, Healthcare]
- Friday, April 20, 2012, 12:55 PM Chemed (CHE -4.9%) dips after posting a mixed Q1, beating on revenue but coming up short on its EPS. Net earnings actually rose 13% on better growth in its hospice-care segment, but margins were pressured by sales declines in its Roto-Rooter business. The company also lowered the top end of its EPS estimate by a nickel, now expecting to earn between $5.35 - $5.50 per share. Comment! [On the Move, Earnings]
- Wednesday, February 15, 2012, 10:58 AM Chemed (CHE +3.9%) moves higher despite missing estimates on its Q4 report yesterday. Net income rose 14% Y/Y, weathering a drop in operating income from its Vitas hospice unit as its Roto-Rooter plumbing business offset the decline with a 28% jump in profit. The company also raises FY12 guidance, now expecting to earn $5.35 - $5.55 per share, above Street expectations of $5.27. 1 Comment [On the Move]
- Tuesday, February 14, 2012, 4:51 PM Chemed (CHE): Q4 EPS of $1.45 may not be comaparable to consensus of $1.48. Revenue of $350M (+4.2% Y/Y) in-line. (PR) 3 Comments [Earnings, Healthcare]
- Thursday, January 5, 2012, 12:31 PM A Bloomberg report about the Justice Department joining a lawsuit against another hospice operator may be contributing to weakness in Chemed (CHE -1.9%) shares. DOJ and the Department of Health and Human Services are already investigating Chemed’s Vitas Healthcare, for “an extensive scheme” to defraud the government of “hundreds of millions of dollars." Comment! [Healthcare, On the Move]
- Wednesday, November 16, 2011, 9:51 AM Shares of Chemed (CHE -7.9%) trade lower after a whistleblower accuses the firm of an extensive Medicare HMO scheme aimed at defrauding the government. The allegations were unveiled in a lawsuit filed in a federal case against the company. Comment! [Healthcare, On the Move]
-
- View all 0 replies
-
Andrew Shapiro
http://1.usa.gov/10wM90I Link to US Justice Dept release charging Chemed and its Vitas Hospice subsidiary for medicare fraud $CHE - View all 8 replies
-
valueinvestor20: Don't think there will be material compliance cost. Some pullback in continuous care business - maybe a 5% hit to earnings. -
valueinvestor20: I would guess settlement is ultimately <$100mm which should not be an issue - company has unlevered balance sheet and is cash generative.
-
Andrew Shapiro
http://on.wsj.com/1008hEQ U.S. Sues Chemed for Vitas' False Medicare Billings Costing 'Tens of Millions of Taxpayer $CHE - View all 0 replies
-
Daniel Long
2 stocks hitting 10 yr highs in our most Undervalued Ind-Home Health Care, in most Overvalued Sec-Healthcare $ADUS $CHE http://bit.ly/Xxbb1g - View all 0 replies
-
- View all 0 replies
-
Andrew Shapiro
http://1.usa.gov/ODEh9T Do #Chemed's #Hospice regulatory subpoenas infer additional risk for #Gentiva's Hospice operations? $CHE $GTIV - View all 0 replies
-
Andrew Shapiro
Do Chemed's VITAS Hospice regulatory subpoenas infer additional risk for Gentiva's Hospice operations? $CHE $GTIV - View all 0 replies
-
Andrew Shapiro
http://1.usa.gov/ODEh9T Chemed 10-CTL regulatory matters - separate July 2012 FLA subpoena for info from 01/2007 too $CHE #hospice - View all 0 replies
-
Andrew Shapiro
http://1.usa.gov/ODEh9T Chemed 10-CTL - regulatory matters - subpoena from OIG for info from 01/2007 to 6/2012 period $CHE #hospice - View all 0 replies
-
Andrew Shapiro
Chemed 10-CTL released with updated regulatory matters language; issued subpoena from OIG for info from 01/2007 to 6/2012 period $CHE - View all 0 replies
LATEST REPLIES
-
Andrew Shapiro
http://1.usa.gov/10wM90I Link to US Justice Dept release charging Chemed and its Vitas Hospice subsidiary for medicare fraud $CHE - View all 8 replies
-
valueinvestor20: Don't think there will be material compliance cost. Some pullback in continuous care business - maybe a 5% hit to earnings.
-
valueinvestor20: I would guess settlement is ultimately <$100mm which should not be an issue - company has unlevered balance sheet and is cash generative.